Wordt geladen...
Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
BACKGROUND: TREM2 is a transmembrane receptor that is predominantly expressed by microglia in the central nervous system. Rare variants in the TREM2 gene increase the risk for late-onset Alzheimer’s disease (AD). Soluble TREM2 (sTREM2) resulting from shedding of the TREM2 ectodomain can be detected...
Bewaard in:
| Gepubliceerd in: | Mol Neurodegener |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327425/ https://ncbi.nlm.nih.gov/pubmed/30630532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-018-0301-5 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|